Investigating a TELEmedicine solution to improve MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>Frequent rehospitalisations and poorer survival chances in heart failure (HF) patients may partly be explained by poor medication adherence. There are multiple medication-related reasons for suboptimal adherence, but psychological re...

Full description

Bibliographic Details
Main Authors: Widdershoven Jos, Denollet Johan, Kessing Dionne, Kupper Nina
Format: Article
Language:English
Published: BMC 2011-10-01
Series:Trials
Subjects:
Online Access:http://www.trialsjournal.com/content/12/1/227
_version_ 1818385622079897600
author Widdershoven Jos
Denollet Johan
Kessing Dionne
Kupper Nina
author_facet Widdershoven Jos
Denollet Johan
Kessing Dionne
Kupper Nina
author_sort Widdershoven Jos
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Frequent rehospitalisations and poorer survival chances in heart failure (HF) patients may partly be explained by poor medication adherence. There are multiple medication-related reasons for suboptimal adherence, but psychological reasons may also be important. A novel TELEmonitoring device may improve MEDication adherence in HF patients (TELEMED-HF). TELEMED-HF is a randomized, controlled clinical intervention trial designed to examine (1) the efficacy and cost-efficiency of an electronic medication adherence support system in improving and monitoring HF patients' medication adherence; (2) the effect of medication adherence on hospitalizations and health care consumption; as well as on (3) clinical characteristics, and Quality of Life (QoL); and (4) clinical, sociodemographic, and psychological determinants of medication adherence.</p> <p>Methods/Design</p> <p>Consecutive patients with chronic, systolic HF presenting to the outpatient clinic of the TweeSteden Hospital, The Netherlands, will be approached for study participation and randomly assigned (1:1) following blocked randomization procedures to the intervention (n = 200) or usual care arm (n = 200). Patients in the intervention arm use the medication support device for six months in addition to usual care. Post-intervention, patients return to usual care only and all patients participate in four follow-up occasions over 12 months. Primary endpoints comprise objective and subjective medication adherence, healthcare consumption, number of hospitalizations, and cost-effectiveness. Secondary endpoints include disease severity, physical functioning, and QoL.</p> <p>Discussion</p> <p>The TELEMED-HF study will provide us a comprehensive understanding of medication adherence in HF patients, and will show whether telemonitoring is effective and cost-efficient in improving adherence and preventing hospitalization in HF patients.</p> <p>Trial registration number</p> <p><a href="http://www.clinicaltrials.gov/ct2/show/NCT01347528">NCT01347528</a>.</p>
first_indexed 2024-12-14T03:41:05Z
format Article
id doaj.art-609e153121ca425ca3bfcc35a0889945
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-12-14T03:41:05Z
publishDate 2011-10-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-609e153121ca425ca3bfcc35a08899452022-12-21T23:18:29ZengBMCTrials1745-62152011-10-0112122710.1186/1745-6215-12-227Investigating a TELEmedicine solution to improve MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trialWiddershoven JosDenollet JohanKessing DionneKupper Nina<p>Abstract</p> <p>Background</p> <p>Frequent rehospitalisations and poorer survival chances in heart failure (HF) patients may partly be explained by poor medication adherence. There are multiple medication-related reasons for suboptimal adherence, but psychological reasons may also be important. A novel TELEmonitoring device may improve MEDication adherence in HF patients (TELEMED-HF). TELEMED-HF is a randomized, controlled clinical intervention trial designed to examine (1) the efficacy and cost-efficiency of an electronic medication adherence support system in improving and monitoring HF patients' medication adherence; (2) the effect of medication adherence on hospitalizations and health care consumption; as well as on (3) clinical characteristics, and Quality of Life (QoL); and (4) clinical, sociodemographic, and psychological determinants of medication adherence.</p> <p>Methods/Design</p> <p>Consecutive patients with chronic, systolic HF presenting to the outpatient clinic of the TweeSteden Hospital, The Netherlands, will be approached for study participation and randomly assigned (1:1) following blocked randomization procedures to the intervention (n = 200) or usual care arm (n = 200). Patients in the intervention arm use the medication support device for six months in addition to usual care. Post-intervention, patients return to usual care only and all patients participate in four follow-up occasions over 12 months. Primary endpoints comprise objective and subjective medication adherence, healthcare consumption, number of hospitalizations, and cost-effectiveness. Secondary endpoints include disease severity, physical functioning, and QoL.</p> <p>Discussion</p> <p>The TELEMED-HF study will provide us a comprehensive understanding of medication adherence in HF patients, and will show whether telemonitoring is effective and cost-efficient in improving adherence and preventing hospitalization in HF patients.</p> <p>Trial registration number</p> <p><a href="http://www.clinicaltrials.gov/ct2/show/NCT01347528">NCT01347528</a>.</p>http://www.trialsjournal.com/content/12/1/227chronic heart failuremedication adherencetelemedicinetelemonitoringintervention trialdeterminants of adherence
spellingShingle Widdershoven Jos
Denollet Johan
Kessing Dionne
Kupper Nina
Investigating a TELEmedicine solution to improve MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trial
Trials
chronic heart failure
medication adherence
telemedicine
telemonitoring
intervention trial
determinants of adherence
title Investigating a TELEmedicine solution to improve MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trial
title_full Investigating a TELEmedicine solution to improve MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trial
title_fullStr Investigating a TELEmedicine solution to improve MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trial
title_full_unstemmed Investigating a TELEmedicine solution to improve MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trial
title_short Investigating a TELEmedicine solution to improve MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trial
title_sort investigating a telemedicine solution to improve medication adherence in chronic heart failure telemed hf study protocol for a randomized controlled trial
topic chronic heart failure
medication adherence
telemedicine
telemonitoring
intervention trial
determinants of adherence
url http://www.trialsjournal.com/content/12/1/227
work_keys_str_mv AT widdershovenjos investigatingatelemedicinesolutiontoimprovemedicationadherenceinchronicheartfailuretelemedhfstudyprotocolforarandomizedcontrolledtrial
AT denolletjohan investigatingatelemedicinesolutiontoimprovemedicationadherenceinchronicheartfailuretelemedhfstudyprotocolforarandomizedcontrolledtrial
AT kessingdionne investigatingatelemedicinesolutiontoimprovemedicationadherenceinchronicheartfailuretelemedhfstudyprotocolforarandomizedcontrolledtrial
AT kuppernina investigatingatelemedicinesolutiontoimprovemedicationadherenceinchronicheartfailuretelemedhfstudyprotocolforarandomizedcontrolledtrial